Verition Fund Management LLC trimmed its stake in Danaher Corporation (NYSE:DHR – Free Report) by 16.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 79,861 shares of the conglomerate’s stock after selling 16,103 shares during the quarter. Verition Fund Management LLC’s holdings in Danaher were worth $18,282,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Elevated Capital Advisors LLC purchased a new stake in Danaher in the fourth quarter valued at approximately $26,000. Hilton Head Capital Partners LLC purchased a new stake in Danaher in the fourth quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd grew its holdings in Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the period. JPL Wealth Management LLC purchased a new stake in Danaher in the third quarter valued at approximately $25,000. Finally, WFA of San Diego LLC purchased a new stake in Danaher in the second quarter valued at approximately $26,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
DHR has been the subject of a number of recent analyst reports. UBS Group lowered their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Piper Sandler started coverage on Danaher in a report on Thursday. They set a “neutral” rating and a $200.00 target price for the company. The Goldman Sachs Group decreased their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 target price on shares of Danaher in a report on Tuesday, April 21st. Finally, TD Cowen decreased their target price on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $233.61.
Danaher Stock Up 0.5%
NYSE DHR opened at $181.04 on Tuesday. The stock has a market cap of $128.13 billion, a PE ratio of 35.02, a P/E/G ratio of 2.30 and a beta of 0.81. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The business has a 50 day moving average price of $180.73 and a two-hundred day moving average price of $204.27. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.88 EPS. As a group, sell-side analysts predict that Danaher Corporation will post 8.45 EPS for the current fiscal year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
